Gross Profit - Dizal Jiangsu Pharmaceutical Co Ltd (SSE:688192) - Alpha Spread
D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 33.4 CNY -7.2%
Market Cap: 13.6B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Dizal Jiangsu Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dizal Jiangsu Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Gross Profit
ÂĄ88.1m
CAGR 3-Years
194%
CAGR 5-Years
76%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Gross Profit
ÂĄ14.7B
CAGR 3-Years
108%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Gross Profit
ÂĄ5.1B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Gross Profit
ÂĄ4.4B
CAGR 3-Years
N/A
CAGR 5-Years
335%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Gross Profit
ÂĄ4.5B
CAGR 3-Years
34%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Gross Profit
ÂĄ11.7B
CAGR 3-Years
3%
CAGR 5-Years
26%
CAGR 10-Years
38%

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
88.1m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Gross Profit amounts to 88.1m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
76%

The average annual Gross Profit growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 194% over the past three years , 76% over the past five years .

Back to Top